{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:13:05Z","timestamp":1791000785657,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81421003"],"award-info":[{"award-number":["81421003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81627807"],"award-info":[{"award-number":["81627807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2017YFC0908300"],"award-info":[{"award-number":["2017YFC0908300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13046-018-0729-z","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:22:56Z","timestamp":1522801376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6\/Rac1\/Cdc42 axis"],"prefix":"10.1186","volume":"37","author":[{"given":"Xiaowei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzuo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6850-3646","authenticated-orcid":false,"given":"Kaichun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"729_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"729_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"729_CR3","doi-asserted-by":"publisher","first-page":"e1000879","DOI":"10.1371\/journal.pgen.1000879","volume":"6","author":"J Tie","year":"2010","unstructured":"Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y, et al. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 2010;6:e1000879.","journal-title":"PLoS Genet"},{"key":"729_CR4","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1136\/gutjnl-2014-308932","volume":"65","author":"SM Wang","year":"2016","unstructured":"Wang SM, Tie J, Wang WL, Hu SJ, Yin JP, Yi XF, Tian ZH, Zhang XY, Li MB, Li ZS, et al. POU2F2-oriented network promotes human gastric cancer metastasis. Gut. 2016;65:1427\u201338.","journal-title":"Gut"},{"key":"729_CR5","doi-asserted-by":"crossref","unstructured":"Jansen S, Gosens R, Wieland T, Schmidt M. Paving the rho in cancer metastasis: rho GTPases and beyond. Pharmacol Ther. 2018;183:1-21.","DOI":"10.1016\/j.pharmthera.2017.09.002"},{"key":"729_CR6","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1158\/0008-5472.CAN-17-1456","volume":"77","author":"MG Kazanietz","year":"2017","unstructured":"Kazanietz MG, Caloca MJ. The Rac GTPase in Cancer: from old concepts to new paradigms. Cancer Res. 2017;77:5445\u201351.","journal-title":"Cancer Res"},{"key":"729_CR7","doi-asserted-by":"publisher","first-page":"e29019","DOI":"10.4161\/sgtp.29019","volume":"5","author":"JL Orgaz","year":"2014","unstructured":"Orgaz JL, Herraiz C, Sanz-Moreno V. Rho GTPases modulate malignant transformation of tumor cells. Small GTPases. 2014;5:e29019.","journal-title":"Small GTPases"},{"key":"729_CR8","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1172\/JCI81673","volume":"125","author":"R Kong","year":"2015","unstructured":"Kong R, Yi F, Wen P, Liu J, Chen X, Ren J, Li X, Shang Y, Nie Y, Wu K, et al. Myo9b is a key player in SLIT\/ROBO-mediated lung tumor suppression. J Clin Invest. 2015;125:4407\u201320.","journal-title":"J Clin Invest"},{"key":"729_CR9","doi-asserted-by":"publisher","first-page":"e29710","DOI":"10.4161\/sgtp.29710","volume":"5","author":"A Sadok","year":"2014","unstructured":"Sadok A, Marshall CJ. Rho GTPases: masters of cell migration. Small GTPases. 2014;5:e29710.","journal-title":"Small GTPases"},{"key":"729_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbrc.2008.12.044","volume":"379","author":"K Li","year":"2009","unstructured":"Li K, Lu Y, Liang J, Luo G, Ren G, Wang X, Fan D. RhoE enhances multidrug resistance of gastric cancer cells by suppressing Bax. Biochem Biophys Res Commun. 2009;379:212\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"729_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00109-007-0217-y","volume":"85","author":"N Liu","year":"2007","unstructured":"Liu N, Zhang G, Bi F, Pan Y, Xue Y, Shi Y, Yao L, Zhao L, Zheng Y, Fan D. RhoC is essential for the metastasis of gastric cancer. J Mol Med (Berl). 2007;85:1149\u201356.","journal-title":"J Mol Med (Berl)"},{"key":"729_CR12","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.bbrc.2004.01.108","volume":"315","author":"Y Pan","year":"2004","unstructured":"Pan Y, Bi F, Liu N, Xue Y, Yao X, Zheng Y, Fan D. Expression of seven main rho family members in gastric carcinoma. Biochem Biophys Res Commun. 2004;315:686\u201391.","journal-title":"Biochem Biophys Res Commun"},{"key":"729_CR13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.bbrc.2004.06.088","volume":"320","author":"Y Xue","year":"2004","unstructured":"Xue Y, Bi F, Zhang X, Pan Y, Liu N, Zheng Y, Fan D. Inhibition of endothelial cell proliferation by targeting Rac1 GTPase with small interference RNA in tumor cells. Biochem Biophys Res Commun. 2004;320:1309\u201315.","journal-title":"Biochem Biophys Res Commun"},{"key":"729_CR14","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1002\/ijc.21763","volume":"118","author":"Y Xue","year":"2006","unstructured":"Xue Y, Bi F, Zhang X, Zhang S, Pan Y, Liu N, Shi Y, Yao X, Zheng Y, Fan D. Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1alpha activation. Int J Cancer. 2006;118:2965\u201372.","journal-title":"Int J Cancer"},{"key":"729_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ejcb.2014.06.003","volume":"93","author":"G Gadea","year":"2014","unstructured":"Gadea G, Blangy A. Dock-family exchange factors in cell migration and disease. Eur J Cell Biol. 2014;93:466\u201377.","journal-title":"Eur J Cell Biol"},{"key":"729_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1101\/gad.236349.113","volume":"28","author":"M Laurin","year":"2014","unstructured":"Laurin M, Cote JF. Insights into the biological functions of Dock family guanine nucleotide exchange factors. Genes Dev. 2014;28:533\u201347.","journal-title":"Genes Dev"},{"key":"729_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.06.005","volume":"43","author":"K Namekata","year":"2014","unstructured":"Namekata K, Kimura A, Kawamura K, Harada C, Harada T. Dock GEFs and their therapeutic potential: neuroprotection and axon regeneration. Prog Retin Eye Res. 2014;43:1\u201316.","journal-title":"Prog Retin Eye Res"},{"key":"729_CR18","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.yexcr.2013.07.024","volume":"319","author":"A Nishikimi","year":"2013","unstructured":"Nishikimi A, Kukimoto-Niino M, Yokoyama S, Fukui Y. Immune regulatory functions of DOCK family proteins in health and disease. Exp Cell Res. 2013;319:2343\u20139.","journal-title":"Exp Cell Res"},{"key":"729_CR19","doi-asserted-by":"publisher","first-page":"13211","DOI":"10.1074\/jbc.M110.102517","volume":"285","author":"L Premkumar","year":"2010","unstructured":"Premkumar L, Bobkov AA, Patel M, Jaroszewski L, Bankston LA, Stec B, Vuori K, Cote JF, Liddington RC. Structural basis of membrane targeting by the Dock180 family of rho family guanine exchange factors (rho-GEFs). J Biol Chem. 2010;285:13211\u201322.","journal-title":"J Biol Chem"},{"key":"729_CR20","doi-asserted-by":"publisher","DOI":"10.4161\/cib.26839","volume":"6","author":"L Shi","year":"2013","unstructured":"Shi L. Dock protein family in brain development and neurological disease. Commun Integr Biol. 2013;6:e26839.","journal-title":"Commun Integr Biol"},{"key":"729_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.cell.2008.09.043","volume":"135","author":"V Sanz-Moreno","year":"2008","unstructured":"Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ. Rac activation and inactivation control plasticity of tumor cell movement. Cell. 2008;135:510\u201323.","journal-title":"Cell"},{"key":"729_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1155\/2010\/397291","volume":"29","author":"SA McGhee","year":"2010","unstructured":"McGhee SA, Chatila TA. DOCK8 immune deficiency as a model for primary cytoskeletal dysfunction. Dis Markers. 2010;29:151\u20136.","journal-title":"Dis Markers"},{"key":"729_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1242\/bio.20149050","volume":"4","author":"N Ruiz-Lafuente","year":"2015","unstructured":"Ruiz-Lafuente N, Alcaraz-Garcia MJ, Garcia-Serna AM, Sebastian-Ruiz S, Moya-Quiles MR, Garcia-Alonso AM, Parrado A. Dock10, a Cdc42 and Rac1 GEF, induces loss of elongation, filopodia, and ruffles in cervical cancer epithelial HeLa cells. Biol Open. 2015;4:627\u201335.","journal-title":"Biol Open"},{"key":"729_CR24","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1016\/j.molimm.2008.04.003","volume":"45","author":"E Yelo","year":"2008","unstructured":"Yelo E, Bernardo MV, Gimeno L, Alcaraz-Garcia MJ, Majado MJ, Parrado A. Dock10, a novel CZH protein selectively induced by interleukin-4 in human B lymphocytes. Mol Immunol. 2008;45:3411\u20138.","journal-title":"Mol Immunol"},{"key":"729_CR25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/bjc.2014.39","volume":"110","author":"DW Murray","year":"2014","unstructured":"Murray DW, Didier S, Chan A, Paulino V, Van Aelst L, Ruggieri R, Tran NL, Byrne AT, Symons M. Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation. Br J Cancer. 2014;110:1307\u201315.","journal-title":"Br J Cancer"},{"key":"729_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.vph.2015.10.003","volume":"74","author":"R Hernandez-Garcia","year":"2015","unstructured":"Hernandez-Garcia R, Iruela-Arispe ML, Reyes-Cruz G, Vazquez-Prado J. Endothelial RhoGEFs: a systematic analysis of their expression profiles in VEGF-stimulated and tumor endothelial cells. Vasc Pharmacol. 2015;74:60\u201372.","journal-title":"Vasc Pharmacol"},{"key":"729_CR27","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.neo.2017.08.003","volume":"19","author":"X Yuan","year":"2017","unstructured":"Yuan X, Wang X, Gu B, Ma Y, Liu Y, Sun M, Kong J, Sun W, Wang H, Zhou F, Gao S. Directional migration in esophageal squamous cell carcinoma (ESCC) is epigenetically regulated by SET nuclear oncogene, a member of the inhibitor of histone Acetyltransferase complex. Neoplasia. 2017;19:868\u201384.","journal-title":"Neoplasia"},{"key":"729_CR28","doi-asserted-by":"publisher","first-page":"ra15","DOI":"10.1126\/scisignal.2003661","volume":"6","author":"Y Miyamoto","year":"2013","unstructured":"Miyamoto Y, Torii T, Yamamori N, Ogata T, Tanoue A, Yamauchi J. Akt and PP2A reciprocally regulate the guanine nucleotide exchange factor Dock6 to control axon growth of sensory neurons. Sci Signal. 2013;6:ra15.","journal-title":"Sci Signal"},{"key":"729_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.febslet.2004.06.095","volume":"572","author":"A Ruusala","year":"2004","unstructured":"Ruusala A, Aspenstrom P. Isolation and characterisation of DOCK8, a member of the DOCK180-related regulators of cell morphology. FEBS Lett. 2004;572:159\u201366.","journal-title":"FEBS Lett"},{"key":"729_CR30","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1053\/j.gastro.2011.08.050","volume":"141","author":"W Bao","year":"2011","unstructured":"Bao W, Fu HJ, Xie QS, Wang L, Zhang R, Guo ZY, Zhao J, Meng YL, Ren XL, Wang T, et al. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology. 2011;141:2076\u201387. e2076","journal-title":"Gastroenterology"},{"key":"729_CR31","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.2147\/OTT.S135664","volume":"10","author":"M Wu","year":"2017","unstructured":"Wu M, Ye X, Wang S, Li Q, Lai Y, Yi Y. MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2. Onco Targets Ther. 2017;10:2815\u201322.","journal-title":"Onco Targets Ther"},{"key":"729_CR32","first-page":"3603","volume":"8","author":"Z Zhou","year":"2015","unstructured":"Zhou Z, Su Y, Fa X. Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b. Onco Targets Ther. 2015;8:3603\u201312.","journal-title":"Onco Targets Ther"},{"key":"729_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3892\/mmr.2015.4500","volume":"13","author":"X Chen","year":"2016","unstructured":"Chen X, Bo L, Lu W, Zhou G, Chen Q. MicroRNA-148b targets rho-associated protein kinase 1 to inhibit cell proliferation, migration and invasion in hepatocellular carcinoma. Mol Med Rep. 2016;13:477\u201382.","journal-title":"Mol Med Rep"},{"key":"729_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1158\/1535-7163.MCT-12-0534-T","volume":"12","author":"G Zhao","year":"2013","unstructured":"Zhao G, Zhang JG, Liu Y, Qin Q, Wang B, Tian K, Liu L, Li X, Niu Y, Deng SC, Wang CY. miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKalpha1. Mol Cancer Ther. 2013;12:83\u201393.","journal-title":"Mol Cancer Ther"},{"key":"729_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/mutage\/geu050","volume":"29","author":"X Chen","year":"2014","unstructured":"Chen X, Wang G, Lu X, Gao P, Song Y, Sun J, Li A, Xu Y, Xu H, Wang Z. Polymorphisms and haplotypes of the miR-148\/152 family are associated with the risk and clinicopathological features of gastric cancer in a northern Chinese population. Mutagenesis. 2014;29:401\u20137.","journal-title":"Mutagenesis"},{"key":"729_CR36","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/cam4.1008","volume":"6","author":"X Ding","year":"2017","unstructured":"Ding X, Liu J, Liu T, Ma Z, Wen D, Zhu J. miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1. Cancer Med. 2017;6:1301\u201310.","journal-title":"Cancer Med"},{"key":"729_CR37","doi-asserted-by":"crossref","unstructured":"Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu HM, Zhang X, Jiang L, Xing CZ, Zhang Y. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer. 2011;10(1):1-13.","DOI":"10.1186\/1476-4598-10-1"},{"key":"729_CR38","doi-asserted-by":"crossref","unstructured":"Dong J, Wang R, Ren G, Li X, Wang J, Sun Y, Liang J, Nie Y, Wu K, Feng B, et al. HMGA2-FOXL2 Axis regulates metastases and epithelial-to-Mesenchymal transition of Chemoresistant gastric Cancer. Clin Cancer Res. 2017;;23(13):3461-73.","DOI":"10.1158\/1078-0432.CCR-16-2180"},{"key":"729_CR39","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/hep.27756","volume":"61","author":"W Huang","year":"2015","unstructured":"Huang W, Chen Z, Shang X, Tian D, Wang D, Wu K, Fan D, Xia L. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1. Hepatology. 2015;61:1920\u201333.","journal-title":"Hepatology"},{"key":"729_CR40","doi-asserted-by":"publisher","first-page":"49322","DOI":"10.18632\/oncotarget.10337","volume":"7","author":"AM Szasz","year":"2016","unstructured":"Szasz AM, Lanczky A, Nagy A, Forster S, Hark K, Green JE, Boussioutas A, Busuttil R, Szabo A, Gyorffy B. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget. 2016;7:49322\u201333.","journal-title":"Oncotarget"},{"key":"729_CR41","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.yexcr.2006.11.017","volume":"313","author":"Y Miyamoto","year":"2007","unstructured":"Miyamoto Y, Yamauchi J, Sanbe A, Tanoue A. Dock6, a Dock-C subfamily guanine nucleotide exchanger, has the dual specificity for Rac1 and Cdc42 and regulates neurite outgrowth. Exp Cell Res. 2007;313:791\u2013804.","journal-title":"Exp Cell Res"},{"key":"729_CR42","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/jcb.25183","volume":"116","author":"K Kim","year":"2015","unstructured":"Kim K, Yang DK, Kim S, Kang H. miR-142-3p is a regulator of the TGFbeta-mediated vascular smooth muscle cell phenotype. J Cell Biochem. 2015;116:2325\u201333.","journal-title":"J Cell Biochem"},{"key":"729_CR43","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA. The cBio Cancer genomics portal: an open platform for exploring multidimensional Cancer genomics data (vol 2, pg 401, 2012). Cancer Discov. 2012;2:960.","journal-title":"Cancer Discov"},{"key":"729_CR44","doi-asserted-by":"publisher","unstructured":"Gao JJ, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun YC, Jacobsen A, Sinha R, Larsson E, et al. Integrative analysis of complex Cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269). \n                    https:\/\/doi.org\/10.1126\/scisignal.2004088\n                    \n                  .","DOI":"10.1126\/scisignal.2004088"},{"key":"729_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.devcel.2016.08.020","volume":"39","author":"B Cerikan","year":"2016","unstructured":"Cerikan B, Shaheen R, Colo GP, Glasser C, Hata S, Knobeloch KP, Alkuraya FS, Fassler R, Schiebel E. Cell-intrinsic adaptation arising from chronic ablation of a key rho GTPase regulator. Dev Cell. 2016;39:28\u201343.","journal-title":"Dev Cell"},{"key":"729_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.devcel.2016.09.020","volume":"39","author":"DJ McGarry","year":"2016","unstructured":"McGarry DJ, Olson MF. Coping with loss: cell adaptation to cytoskeleton disruption. Dev Cell. 2016;39:3\u20134.","journal-title":"Dev Cell"},{"key":"729_CR47","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/15384101.2016.1256153","volume":"16","author":"B Cerikan","year":"2017","unstructured":"Cerikan B, Schiebel E. DOCK6 inactivation highlights ISGylation as RHO-GTPase balancer. Cell Cycle. 2017;16:304\u20135.","journal-title":"Cell Cycle"},{"key":"729_CR48","unstructured":"Cerikan B, Schiebel E. Mechanism of cell-intrinsic adaptation to Adams-Oliver syndrome gene DOCK6 disruption highlights ubiquitin-like modifier ISG15 as a regulator of RHO GTPases. Small GTPases. 2017;23:1\u20138."}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0729-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-018-0729-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0729-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T21:20:58Z","timestamp":1553635258000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-018-0729-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1186\/s13046-018-0729-z","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"18 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were approved by the Institutional Review Board of Xijing Hospital. Animal experiments were performed with the approval of the Institutional Committee for Animal Research and in accordance with national guidelines for the care and use of laboratory animals. Written informed consent was obtained from all of the patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"71"}}